Meet Gordon Mills, MD, PhD
OHSU announced that internationally renowned scientist Gordon B. Mills, MD, PhD, has been recruited to lead precision oncology for the Knight Cancer Institute. Here are a few interesting facts about him.
All Stories
Gordon B. Mills on the next revolution in cancer
Gordon B. Mills, M.D., Ph.D., is the new director of precision oncology at the OHSU Knight Cancer Institute. His role will be to provide an “integrative force” across various efforts in progress at the institute, including the Cancer Early Detection Advanced Research (CEDAR) Center, immuno-oncology and the system biology groups. In this video, Mills talks […]
Can kids’ immune systems combat cancer?
Treatments for childhood cancers are harsh on kids’ bodies. While survival rates have improved dramatically over the last few decades, quality of life has not. Therapies such as chemotherapy and radiation can lead to learning disabilities, nerve damage, fertility issues and other health problems. OHSU cancer researchers are working to change that. Monika Davare, PhD, […]
A new age of cancer research
The OHSU Knight Cancer Institute has launched the largest program of its kind in the world: the Center for Cancer Early Detection and Research (CEDAR). Early detection remains one of the largest unmet needs in cancer research — yet we know that when we find and treat cancer earlier, more people live. That’s easy to […]
Q&A with Dr. Yoon-Jae Cho
OHSU Doernbecher Children’s Hospital has recruited Yoon-Jae Cho, M.D., thanks to a new endowed professorship from Wayne and Sandy Ericksen. Dr. Cho is the chief of the Division of Pediatric Neurology, Ericksen Family Endowed Professor for Research, and scientific director of the Pediatric Brain Tumor Program. He is also a graduate of OHSU School of […]
Engineering a new future in cancer care
OHSU Knight Cancer Institute Director Brian Druker, M.D., is famous for ignoring the conventional wisdom. He disregarded those who called his research “voodoo science” and his work resulted in GleevecTM – a landmark drug proven effective in 10 types of cancer. In selecting Sadik Esener, Ph.D., to lead the institute’s newly established Center for Early […]
